End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Mar. 18 | Pharmaceutical Groups Idorsia, Viatris Finalize Collaboration to Develop Selatogrel, Cenerimod | MT |
Mar. 12 | Insud Pharma S.L.U. acquired Women Healthcare business of Viatris Inc.. | CI |
Financials (USD)
Sales 2024 * | 15.2B | Sales 2025 * | 14.92B | Capitalization | 13.97B |
---|---|---|---|---|---|
Net income 2024 * | 1.88B | Net income 2025 * | 989M | EV / Sales 2024 * | 1.79 x |
Net Debt 2024 * | 13.28B | Net Debt 2025 * | 11.4B | EV / Sales 2025 * | 1.7 x |
P/E ratio 2024 * |
8.12
x | P/E ratio 2025 * |
13.6
x | Employees | - |
Yield 2024 * |
4.27% | Yield 2025 * |
4.45% | Free-Float | 97.93% |
Latest transcript on Mylan Inc
Managers | Title | Age | Since |
---|---|---|---|
Scott Smith
CEO | Chief Executive Officer | 61 | 22-12-28 |
Rajiv Malik
PSD | President | 63 | 20-11-15 |
David Bayles
CMP | Compliance Officer | - | 20-11-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Melina Higgins
CHM | Chairman | 56 | 20-11-15 |
Mark Parrish
BRD | Director/Board Member | 68 | 20-11-15 |
Harry Korman
BRD | Director/Board Member | 66 | 20-11-15 |
1st Jan change | Capi. | |
---|---|---|
+30.83% | 687B | |
+31.08% | 595B | |
+0.01% | 378B | |
+15.18% | 316B | |
+11.39% | 308B | |
+0.54% | 211B | |
-5.71% | 208B | |
-3.74% | 203B | |
-3.72% | 157B |
- Stock
- Equities
- Stock Viatris Inc.
- Stock Mylan Inc - Nasdaq